TLR2 promotes cellular senescence and inflammation in mice, with both changes replicated by independent labs. One group reports an association with frailty in human nonagenarians. It induces cell-cycle regulation in mouse cells undergoing oncogene-induced senescence but inhibits it in Glis2-knockout mouse kidneys.
46 findings in 27 papers from 2016 to 2026, 3 of them since June 2026
The findings reach people, from one lab or study; independent labs found the same change in mice. 20 independent labs in 11 countries.
“increased expression of IL1B and TLR2 genes is associated with the development of frailty in nonagenarians”
Mice: replicated by independent labs. Cells and humans: a single group. Worms or flies: nothing yet.
C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.
Labs are independent when their papers share no last author and no institution.
Against: findings that point the other way from most findings on the same outcome.
Includes the processes named after it and trials of drugs aimed at it.
20 independent labs in 11 countries
1 finding against
Funders: Deutsche Forschungsgemeinschaft and others
Human trial8
Humans26
Animals50
Cells10
In silico3
Interventions
1
O-vanillin
↓downin human cells1
1 study
O-vanillin decreases TLR2 in human cells after TLR-2/6 agonist induction.
Mouse knockout experiments link TLR2 to increased pancreatic islet fibrosis, hypertrophy and beta-cell mass expansion in males; mouse STC-1 cells show increased pSer129 alpha-synuclein and fibril uptake. Five findings span two independent labs, with no reported independent replication or human results. Austrian Science Fund and Deutsche Forschungsgemeinschaft each fund three findings.
Experiments in lab-grown human retinal pigment cells found changes associated with senescence, a state in which cells stop dividing.Experiments in lab-grown human retinal pigment cells found changes associated with senescence, a state in which cells stop dividing.
In a model of hormone-producing intestinal cells, the receptor increased uptake and chemical tagging of alpha-synuclein, a protein implicated in Parkinson’s disease.In a model of hormone-producing intestinal cells, the receptor increased uptake and chemical tagging of alpha-synuclein, a protein implicated in Parkinson’s disease.